16 November 2026 Punjab Khabarnama Bureau  :   India recorded approximately 2.63 lakh tuberculosis (TB)-related deaths in 2025, highlighting the continuing challenge of eliminating the infectious disease despite improvements in diagnosis and treatment. The findings have raised fresh questions about India’s progress towards its tuberculosis elimination targets, particularly after the World Health Organization (WHO) released its Global Tuberculosis Report 2026.

According to the report, India continues to carry one of the world’s largest tuberculosis burdens, accounting for approximately 25 per cent of global TB cases and 23 per cent of worldwide deaths from the disease. A total of 25.3 lakh TB cases were notified under India’s national programme in 2025, compared with 26.18 lakh cases in 2024. The number of reported deaths also declined from just over three lakh in 2024 to 2.63 lakh in 2025.

Although these figures indicate progress, public health experts and advocacy organisations believe that the number of deaths remains a serious concern. Tuberculosis is both preventable and curable, yet millions of people continue to suffer from the disease, particularly those living in economically vulnerable conditions.

The Jan Swasthya Abhiyan India (JSAI) has questioned the government’s claims of rapid progress towards eliminating tuberculosis. In a statement issued on November 14, the organisation highlighted the continuing death toll and gaps in publicly available disease data. It called for greater transparency, stronger public healthcare services and increased investment in TB prevention and treatment.

One of the major concerns highlighted by the latest WHO report is the absence of India’s updated TB incidence estimates. These estimates are important because they indicate the number of people developing tuberculosis in a particular year, including individuals who have not yet been diagnosed or registered under the national health programme.

The WHO has stated that India’s incidence estimates and related indicators are currently under review. The assessment is pending the finalisation and analysis of data collected through district-level sentinel surveillance. Updated estimates are expected to be available in early 2027.

India conducted a district-level surveillance exercise in 2025 covering 50 representative districts. The findings are being examined to establish reliable estimates of the country’s tuberculosis burden. Until this process is completed, the latest global report does not provide an updated incidence estimate for India.

The absence of this information has also attracted criticism from public health advocates, who argue that transparent and regularly updated data are essential for measuring the effectiveness of elimination programmes. JSAI has also expressed concern over the delay in publishing India’s annual TB report, which traditionally provides detailed information about cases, treatment and disease trends across states and districts.

Another important issue is India’s progress towards the WHO’s End TB targets. The international strategy established 2015 as the baseline year and set specific targets for reducing tuberculosis cases and deaths. The target was to reduce TB mortality by 35 per cent by 2020 and 75 per cent by 2025.

India has recorded a 38 per cent reduction in estimated TB mortality between 2015 and 2025. The mortality rate declined from 28 deaths per lakh population in 2015 to 18 deaths per lakh in 2025. However, the country achieved the earlier 2020 milestone approximately five years behind schedule and remains considerably short of the 2025 target.

The government, meanwhile, has highlighted several improvements in its tuberculosis control programme. According to the Union Health Ministry, India has achieved a 94 per cent treatment success rate among patients with drug-susceptible TB. The government has also expanded screening facilities, rapid diagnostic testing and nutritional assistance for patients.

Under the TB Mukt Bharat Abhiyaan, more than 25 crore people have been screened. The programme has included over 11 crore chest X-ray examinations and approximately three crore molecular tests. These efforts helped identify 48.64 lakh TB cases, including nearly 14.97 lakh asymptomatic cases.

Rapid diagnostic testing also increased during 2025, with approximately 46 per cent of notified cases diagnosed through rapid testing, compared with 38 per cent in the previous year.

Despite these improvements, drug-resistant tuberculosis remains another significant challenge. India has one of the largest gaps between estimated cases of rifampicin-resistant tuberculosis and patients who actually receive treatment. Delays in drug-susceptibility testing, limited diagnostic facilities and interruptions in treatment can make the situation more difficult.

JSAI has called for better access to advanced diagnostic facilities, particularly in rural and underserved areas. It has also stressed the need to ensure that patients receive appropriate medicines without unnecessary delays.

The financial and nutritional challenges faced by TB patients have also become an important part of the discussion. Although anti-tuberculosis medicines are available free of cost through government healthcare facilities, patients often face additional expenses related to travel, private consultations, diagnostic tests and loss of income during treatment.

The government’s Ni-kshay Poshan Yojana provides financial assistance for the nutritional needs of tuberculosis patients. Community initiatives such as Ni-kshay Mitra also encourage individuals and organisations to support patients through nutritional assistance.

However, JSAI believes that existing support is insufficient for many economically disadvantaged families. The organisation has called for more reliable financial assistance, timely payments and stronger social security measures.

It has also highlighted the relationship between tuberculosis and poor living and working conditions. Undernutrition, overcrowded housing, poverty and exposure to hazardous workplace environments can increase the risk of developing the disease. Workers exposed to silica dust in mining, construction, stone quarries and other industries face additional risks because silicosis can increase their vulnerability to tuberculosis.

The organisation has therefore urged authorities to strengthen occupational health screening and ensure that workers suffering from silicosis receive appropriate medical attention.

Overall, the WHO report presents a mixed picture of India’s tuberculosis control efforts. The decline in mortality, expansion of screening and improvement in treatment outcomes represent important progress. However, the continued loss of 2.63 lakh lives in a single year and the absence of updated incidence estimates underline the scale of the remaining challenge.

India’s goal of eliminating tuberculosis will require sustained investment, transparent data, early diagnosis, effective treatment and stronger support for vulnerable communities. Public health organisations have stressed that achieving a TB-free country will depend not only on medical interventions but also on addressing the social and economic conditions that allow the disease to continue spreading.

Punjab Khabarnama

Leave a Reply

Your email address will not be published. Required fields are marked *